Literature DB >> 21617452

Immediate locally advanced breast cancer and chest wall reconstruction: surgical planning and reconstruction strategies with extended V-Y latissimus dorsi myocutaneous flap.

Alexandre Mendonça Munhoz1, Eduardo Montag, Eduardo Arruda, Alberto Okada, José Augusto Brasil, Rolf Gemperli, José Roberto Filassi, Marcus Castro Ferreira.   

Abstract

BACKGROUND: Surgical resection in locally advanced breast cancer produces large defects that may not be suitable for primary closure. Immediate reconstruction is controversial and presents a complicated scenario for breast surgeons and plastic surgeons.
METHODS: In this study, a different design was planned for the latissimus dorsi musculocutaneous flap with primary closure in V-Y for the correction of major lesions in the anterior chest wall. Twenty-five patients underwent immediate locally advanced breast cancer reconstruction with a V-Y latissimus dorsi musculocutaneous flap. This flap was raised from adjacent tissue located on the lateral and posterior thoracic region and presented a triangular shape whose base was the lateral aspect of the mastectomy wound. The technique was indicated in patients with large thoracic wounds.
RESULTS: Mean follow-up time was 16 months. Closure was obtained in the donor and recipient sites without the use of skin grafts or other more major procedures. Complications occurred in nine patients (36 percent), including dorsal wound dehiscence in five patients and seroma in three. All cases except one were treated by a conservative approach with a good result. No total flap loss was reported. All patients achieved a satisfactory thoracic reconstruction and adequate wound care.
CONCLUSIONS: The V-Y latissimus dorsi musculocutaneous flap is a reliable technique for immediate locally advanced breast cancer reconstruction. The technique is advantageous because the V-Y design allows primary closure of the chest wound and donor defect. Success depends on patient selection, coordinated planning with the breast cancer surgeon, and careful intraoperative management.

Entities:  

Mesh:

Year:  2011        PMID: 21617452     DOI: 10.1097/PRS.0b013e318213a038

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  [Application of modified designed bilobed latissimus dorsi myocutaneous flap in chest wall reconstruction of locally advanced breast cancer patients].

Authors:  Lei Wang; Dajiang Song; Aili Song; Zan Li; Bo Zhou; Chunliu Lü; Yuanyuan Tang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-09-15

2.  Management of giant inferior triangle lumbar hernia (Petit's triangle hernia): A rare complication following delayed breast reconstruction with extended latissimus dorsi myocutaneous flap.

Authors:  Alexandre Mendonça Munhoz; Eduardo Montag; Eduardo Gustavo Arruda; Gustavo Sturtz; Rolf Gemperli
Journal:  Int J Surg Case Rep       Date:  2014-04-02

3.  Reconstruction with a 180-degree Rotationally Divided Latissimus-dorsi-musculocutaneous Flap after the Removal of Locally Advanced Breast Cancer.

Authors:  Hajime Matsumine; Miho Kirita; Hiroyuki Sakurai
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-10-07

4.  Multiple pedicled flaps cover for large defects following resection of malignant tumors with partition concept.

Authors:  Chenyang Ji; Ruiting Li; Grace Shen; Jinming Zhang; Weiqiang Liang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

5.  Use of Double Myocutaneous Flap after Extended Resection of Locally Advanced Ulcerated Breast Carcinoma.

Authors:  René Aloisio da Costa Vieira; Luiz Carlos Navarro de Oliveira; An Wan Ching; Idam de Oliveira-Junior
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-22

6.  Locally Advanced Breast Cancer: Autologous Versus Implant-based Reconstruction.

Authors:  Grigorios Tanos; Elena Prousskaia; Whitney Chow; Anna Angelaki; Cleona Cirwan; Hisham Hamed; Jian Farhadi
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.